SGLT2 Inhibitors in Geographic Atrophy (NCT07174687)
Efficacy of Dapagliflozin in the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
🩺 Plain-English Summary (8th-Grade Level)
AMD is a leading cause of blindness in individuals over 50 years old, with dry AMD being the most common form. Geographic atrophy (GA) is an advanced stage of dry AMD characterized by progressive retinal cell degeneration. The primary objectives of the study are to assess the safety, tolerability, and evidence of activity of SGLT2 inhibitors in subjects with Geographic Atrophy associated with AMD.
Who can join: Review the eligibility criteria below.
Location: Washington University — St Louis, Missouri
Age range: 50 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Washington University — St Louis, Missouri
📞 Contact the Study Coordinator
Phone: (314) 286-2946
Email: adcockl@wustl.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Retinal Degeneration
- Natural History of Eye Diseases Related to ABCA4 Mutations — Bethesda, Maryland
- Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F — San Francisco, California
- Rod and Cone Mediated Function in Retinal Disease — Bethesda, Maryland
- Adaptive Optics Imaging of Outer Retinal Diseases — Bethesda, Maryland
Explore by condition: All Retinal Degeneration clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.